JPRN-jRCT2080220391未知3 期
A double-blind, placebo-controlled study of OPC-41061 in the treatment of cardiac edema (congestive heart failure)
试验速览
- 阶段
- 3 期
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 85age old（—）
- 性别
- All
入选标准
- •(1) Subjects receiving one of the following diuretic treatments (including subjects scheduled to start treatment during the run-in observation period
- •1) A loop diuretic at a daily dosage equivalent to 40 mg or more of furosemide
- •2) Concomitant administration of a loop diuretic and a thiazide diuretic (at any doses)
- •3) Concomitant administration of a loop diuretic and an anti-aldosterone drug (at any doses)
- •(2) CHF patients with lower limb edema, jugular venous distention, or pulmonary congestion due to extracellular volume expansion. Patients with pulmonary congestion can be enrolled if pulmonary congestion is confirmed on chest x-ray taken within 14 days prior to the screening examination.
- •(3) Male or female subjects age 20 or older and younger than 85 (at time of informed consent)
- •(4) Subjects who are able to stay at the study site from the day before the start of the run-in observation period until completion of postdosing examination 2 (7 to 10 days after final study drug administration)
- •(5) Subjects capable of giving informed consent to participate in the study of their own free will
排除标准
- 未提供
研究者
相似试验
已完成
3 期
A Double-blind, Placebo-controlled Study of OPC-41061 in the Treatment of Cardiac Edema (Congestive Heart Failure)Edema, CardiacNCT00462670Otsuka Pharmaceutical Co., Ltd.110
进行中（未招募）
1 期
A Clinical Study to test the effect of the drug MEDI-551 in Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorderseuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders (NMO/NMOSD)MedDRA version: 20.0Level: LLTClassification code 10029322Term: Neuromyelitis opticaSystem Organ Class: 100000004852EUCTR2014-000253-36-CZMedImmune LLC231
进行中（未招募）
1 期
A Clinical Study to test the effect of the drug MEDI-551 in Neuromyelitis Optica and Neuromyelitis Optica Spectrum DisordersEUCTR2014-000253-36-DEMedImmune LLC231
进行中（未招募）
1 期
A Clinical Study to test the effect of the drug MEDI-551 in Neuromyelitis Optica and Neuromyelitis Optica Spectrum DisordersEUCTR2014-000253-36-HUMedImmune LLC252
进行中（未招募）
1 期
A Clinical Study to test the effect of the drug MEDI-551 in Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorderseuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders (NMO/NMOSD)MedDRA version: 20.0 Level: LLT Classification code 10029322 Term: Neuromyelitis optica System Organ Class: 100000004852EUCTR2014-000253-36-BGMedImmune LLC231